Cargando…
XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long-Term Follow-Up
This study aimed to analyze the surgical and refractive outcomes of XEN glaucoma implant (Allergan, an Abbvie company, Irvine, CA, USA), a minimally invasive surgical device for the treatment of operated uncontrolled glaucoma. Eyes that received XEN Gel Stent placement from December 2014 to October...
Autores principales: | Lewczuk, Katarzyna, Konopińska, Joanna, Jabłońska, Joanna, Rudowicz, Jacek, Laszewicz, Patrycja, Mariak, Zofia, Rękas, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285170/ https://www.ncbi.nlm.nih.gov/pubmed/34306742 http://dx.doi.org/10.1155/2021/2321922 |
Ejemplares similares
-
XEN Glaucoma Implant for the Management of Glaucoma in Naïve Patients versus Patients with Previous Glaucoma Surgery
por: Lewczuk, Katarzyna, et al.
Publicado: (2021) -
Microinvasive glaucoma surgery: a review and classification of implant‐dependent procedures and techniques
por: Jabłońska, Joanna, et al.
Publicado: (2021) -
Microinvasive Glaucoma Surgery: A Review of Schlemm’s Canal-Based Procedures
por: Konopińska, Joanna, et al.
Publicado: (2021) -
Treatment of Open-Angle Glaucoma with iStent Implantation Combined with Phacoemulsification in Polish Caucasian Population
por: Kozera, Milena, et al.
Publicado: (2021) -
Schlemm's canal: the outflow ‘vessel’
por: Lewczuk, Katarzyna, et al.
Publicado: (2021)